Eko Analysis Software vs Ligence Heart
AI Verdict
Choose Eko Analysis Software if…
Choose Eko Analysis Software if your primary need is AI-powered assistance for early detection of cardiovascular conditions like heart murmurs and atrial fibrillation during routine physical exams or remote monitoring. This tool is ideal for clinicians who utilize digital stethoscopes and require immediate, point-of-care insights from auscultation and basic ECGs, along with secure recording and playback capabilities.
View Eko Analysis Software →Choose Ligence Heart if…
Choose Ligence Heart if your cardiology department or echo lab requires advanced automation for the analysis and reporting of 2D transthoracic echocardiography studies. This platform is best suited for enhancing diagnostic efficiency and accuracy by automatically classifying views, calculating measurements, and generating comprehensive reports for a wide range of cardiac conditions, seamlessly integrating with existing PACS and EHR systems.
View Ligence Heart →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Analysis Software | Ligence Heart |
|---|---|---|
| Pricing | Freemium with subscription for full features | Contact-for-pricing |
| Deployment | Cloud-based | Cloud-based; on-premise; hybrid |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Ligence HeartWhile Eko's mobile-first approach offers convenient point-of-care usability, Ligence Heart's web-based platform is specifically designed to streamline complex echocardiography analysis. Its emphasis on automated measurements and 'no manual tracing needed' features suggests a higher degree of workflow simplification and ease of use for its specialized function.
Clinical Value
Ligence HeartBoth tools provide significant, FDA-cleared clinical value. Eko excels in early detection and screening for common cardiovascular conditions at the point of care. However, Ligence Heart demonstrates a higher level of clinical impact by automating comprehensive echocardiography analysis, with studies showing its accuracy to be non-inferior to, and in some cases surpassing, human experts for a broader range of specific disease recognition and complex measurements.
Pricing & Value
Eko Analysis SoftwareEko Analysis Software offers a more transparent freemium model, allowing users to access basic features for free and view detailed subscription pricing within the app. In contrast, Ligence Heart uses an enterprise pricing model that requires direct contact for quotes, making its initial value proposition less transparent to potential users.
Enterprise Readiness
Ligence HeartLigence Heart demonstrates superior enterprise readiness by offering flexible deployment options including cloud, on-premise, and hybrid, alongside explicit integration capabilities with hospital systems like PACS, EHR, and RIS. While Eko is HIPAA compliant and cloud-based, its primary focus appears to be individual clinician use, lacking the broad system integration details Ligence provides.
Innovation
Ligence HeartBoth tools are highly innovative, with Eko bringing AI-powered screening to the point of care through connected stethoscopes. However, Ligence Heart's innovation in fully automating complex echocardiogram analysis, including measurements and disease recognition, with demonstrated performance that has in some studies surpassed human experts, represents a more profound and specialized technological leap in diagnostic imaging.
Support & Docs
TieBoth Eko Analysis Software and Ligence Heart offer accessible support and documentation. Eko provides a comprehensive online Help Center, user manuals, and direct contact options including email and scheduled calls. Ligence also offers user manuals in multiple languages and direct email support. Without further specific details on the quality or responsiveness of their support, it is difficult to distinguish a clear winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Analysis Software | Ligence Heart |
|---|---|---|
| Tool Name | Eko Analysis Software | Ligence Heart |
| Company | Eko Devices | Ligence |
| Description | FDA-cleared AI-powered tool that integrates with Eko's digital stethoscopes and mobile app to assist clinicians in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation. | AI-powered web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency and accuracy for cardiologists and sonographers. |
| Primary Function | AI for heart murmur and atrial fibrillation detection using digital stethoscopes and mobile app. | Automated analysis and reporting of 2D transthoracic echocardiography. |
| Key AI Detections/Analysis | FDA-cleared AI for heart murmur detection; FDA-cleared AI for atrial fibrillation (AFib) detection; Detection of normal sinus rhythm; Calculation of cardiac time intervals (heart rate, QRS duration). | Automated recognition of echocardiography imaging data; Automated view classification and heart phase prediction; Automated calculation of measurements and report generation; Disease recognition (Heart failure, cardiomyopathy, pulmonary hypertension, valvular heart diseases); Automated strain, Spectral and Tissue Doppler measurements. |
| Integration Capabilities | Integrates with Eko's digital stethoscopes and mobile app. Telehealth livestreaming requires a paid subscription. | Transfer of echocardiography images (PHI removed) from hospital PACS; Integration with existing systems (PACS, EHR, RIS). |
Videos
Demos, reviews, and walkthroughs featuring Eko Analysis Software and Ligence Heart.